156 related articles for article (PubMed ID: 16490928)
21. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
[TBL] [Abstract][Full Text] [Related]
22. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
[TBL] [Abstract][Full Text] [Related]
23. Nucleotide sequences of three H-2K and three H-2D complementary DNA clones coding mouse class I MHC heavy chain proteins.
Wang M; Stepkowski SM; Hebert JS; Tian L; Yu J; Kahan BD
Ann Transplant; 1996; 1(3):26-31. PubMed ID: 9869916
[TBL] [Abstract][Full Text] [Related]
24. Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.
Chen X; Yan Y; Lu S; Weng X; Liang Z; Li J; Zhong M; Tang J; Xiao W; Sun W; Shen G; Wu X
Hum Immunol; 2009 Feb; 70(2):79-84. PubMed ID: 19100802
[TBL] [Abstract][Full Text] [Related]
25. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
[TBL] [Abstract][Full Text] [Related]
26. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
Mayumi H; Good RA
J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
[TBL] [Abstract][Full Text] [Related]
27. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
Rosenberg AS; Munitz TI; Maniero TG; Singer A
J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
[TBL] [Abstract][Full Text] [Related]
28. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
29. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
Felix NJ; de Serres S; Meyer AA; Ting JP
J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
[TBL] [Abstract][Full Text] [Related]
31. Staphylococcal enterotoxins bind H-2Db molecules on macrophages.
Beharka AA; Iandolo JJ; Chapes SK
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6294-8. PubMed ID: 7603985
[TBL] [Abstract][Full Text] [Related]
32. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice.
He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA
Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809
[TBL] [Abstract][Full Text] [Related]
33. Down-regulated expression of monocyte/macrophage major histocompatibility complex receptors in human and mouse monocytes by expression of their ligands.
Yamana H; Tashiro-Yamaji J; Hayashi M; Maeda S; Shimizu T; Tanigawa N; Uchiyama K; Kubota T; Yoshida R
Clin Exp Immunol; 2014 Oct; 178(1):118-28. PubMed ID: 24842626
[TBL] [Abstract][Full Text] [Related]
34. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
35. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.
Wise M; Zelenika D; Bemelman F; Latinne D; Bazin H; Cobbold S; Waldmann H
Eur J Immunol; 1999 Jan; 29(1):156-67. PubMed ID: 9933097
[TBL] [Abstract][Full Text] [Related]
36. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
[TBL] [Abstract][Full Text] [Related]
37. Introduction of H-2Dd determinants into the H-2Ld antigen by site-directed mutagenesis.
Koeller D; Lieberman R; Miyazaki J; Appella E; Ozato K; Mann DW; Forman J
J Exp Med; 1987 Sep; 166(3):744-60. PubMed ID: 2442290
[TBL] [Abstract][Full Text] [Related]
38. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
39. Antigenicity of passively acquired major histocompatibility antigens on T cells.
Swartz TJ; Evavold B; Suzuki H; Yokoyama A; Quintans J
Transplantation; 1988 Jul; 46(1):137-43. PubMed ID: 3260698
[TBL] [Abstract][Full Text] [Related]
40. Major histocompatibility complex class I presentation of exogenously acquired minor alloantigens initiates skin allograft rejection.
Oukka M; Galou M; Belkaid Y; Tricotet V; Riche N; Reynes M; Kosmatopoulos K
Eur J Immunol; 1997 Dec; 27(12):3499-506. PubMed ID: 9464840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
